{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T07:12:24Z","timestamp":1763536344542,"version":"3.37.3"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,2,18]]},"DOI":"10.7759\/cureus.79252","type":"journal-article","created":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T02:04:12Z","timestamp":1739930652000},"source":"Crossref","is-referenced-by-count":2,"title":["Importance of Genotype-Phenotype Correlation in the Population Screening of Familial Hypercholesterolemia"],"prefix":"10.7759","author":[{"given":"Tuhina","family":"Das","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saikat","family":"Mondal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anup K","family":"Rawool","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Swarnava","family":"Tarafdar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anirban","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2020.03.057","article-title":"Worldwide prevalence of familial hypercholesterolemia: meta-analyses of 11 million subjects","volume":"75","author":"Beheshti SO","year":"2020","unstructured":"Beheshti SO, Madsen CM, Varbo A, Nordestgaard BG. Worldwide prevalence of familial hypercholesterolemia: meta-analyses of 11 million subjects. J Am Coll Cardiol. 2020, 75:2553-66. 10.1016\/j.jacc.2020.03.057","journal-title":"J Am Coll Cardiol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)02001-8","article-title":"Worldwide experience of homozygous familial hypercholesterolaemia: retrospective cohort study","volume":"399","author":"Tromp TR","year":"2022","unstructured":"Tromp TR, Hartgers ML, Hovingh GK, et al.. Worldwide experience of homozygous familial hypercholesterolaemia: retrospective cohort study. Lancet. 2022, 399:719-28. 10.1016\/S0140-6736(21)02001-8","journal-title":"Lancet"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2016.10.028","article-title":"Spectrum of mutations in homozygous familial hypercholesterolemia in India, with four novel mutations","volume":"255","author":"Setia N","year":"2016","unstructured":"Setia N, Saxena R, Arora A, Verma IC. Spectrum of mutations in homozygous familial hypercholesterolemia in India, with four novel mutations. Atherosclerosis. 2016, 255:31-6. 10.1016\/j.atherosclerosis.2016.10.028","journal-title":"Atherosclerosis"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehad197","article-title":"2023 Update on European Atherosclerosis Society Consensus Statement on Homozygous Familial Hypercholesterolaemia: new treatments and clinical guidance","volume":"44","author":"Cuchel M","year":"2023","unstructured":"Cuchel M, Raal FJ, Hegele RA, et al.. 2023 Update on European Atherosclerosis Society Consensus Statement on Homozygous Familial Hypercholesterolaemia: new treatments and clinical guidance. Eur Heart J. 2023, 44:2277-91. 10.1093\/eurheartj\/ehad197","journal-title":"Eur Heart J"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1124\/pr.58.3.1","article-title":"Functionally defective high-density lipoprotein: a new therapeutic target at the crossroads of dyslipidemia, inflammation, and atherosclerosis","volume":"58","author":"Kontush A","year":"2006","unstructured":"Kontush A, Chapman MJ. Functionally defective high-density lipoprotein: a new therapeutic target at the crossroads of dyslipidemia, inflammation, and atherosclerosis. Pharmacol Rev. 2006, 58:342-74. 10.1124\/pr.58.3.1","journal-title":"Pharmacol Rev"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2022.147084","article-title":"LDLR missense variants disturb structural conformation and LDLR activity in T-lymphocytes of Familial hypercholesterolemia patients","volume":"853","author":"Barbosa TK","year":"2023","unstructured":"Barbosa TK, Hirata RD, Ferreira GM, et al.. LDLR missense variants disturb structural conformation and LDLR activity in T-lymphocytes of Familial hypercholesterolemia patients. Gene. 2023, 853:147084. 10.1016\/j.gene.2022.147084","journal-title":"Gene"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2014.11.009","article-title":"Familial hypercholesterolemia in Brazil: cascade screening program, clinical and genetic aspects","volume":"238","author":"Jannes CE","year":"2015","unstructured":"Jannes CE, Santos RD, de Souza Silva PR, et al.. Familial hypercholesterolemia in Brazil: cascade screening program, clinical and genetic aspects. Atherosclerosis. 2015, 238:101-7. 10.1016\/j.atherosclerosis.2014.11.009","journal-title":"Atherosclerosis"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2018.12.003","article-title":"Systematic prediction of familial hypercholesterolemia caused by low-density lipoprotein receptor missense mutations","volume":"281","author":"Guo J","year":"2019","unstructured":"Guo J, Gao Y, Li X, et al.. Systematic prediction of familial hypercholesterolemia caused by low-density lipoprotein receptor missense mutations. Atherosclerosis. 2019, 281:1-8. 10.1016\/j.atherosclerosis.2018.12.003","journal-title":"Atherosclerosis"},{"key":"ref9","doi-asserted-by":"crossref","DOI":"10.1210\/jc.2002-021487","article-title":"Clinical features and genetic analysis of autosomal recessive hypercholesterolemia","volume":"88","author":"Harada-Shiba M","year":"2003","unstructured":"Harada-Shiba M, Takagi A, Miyamoto Y, Tsushima M, Ikeda Y, Yokoyama S, Yamamoto A. Clinical features and genetic analysis of autosomal recessive hypercholesterolemia. J Clin Endocrinol Metab. 2003, 88:2541-7.","journal-title":"J Clin Endocrinol Metab"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajhg.2009.03.010","article-title":"DECIPHER: Database of Chromosomal Imbalance and Phenotype in Humans Using Ensembl Resources","volume":"84","author":"Firth HV","year":"2009","unstructured":"Firth HV, Richards SM, Bevan AP, et al.. DECIPHER: Database of Chromosomal Imbalance and Phenotype in Humans Using Ensembl Resources. Am J Hum Genet. 2009, 84:524-33. 10.1016\/j.ajhg.2009.03.010","journal-title":"Am J Hum Genet"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3892\/br.2020.1391","article-title":"Identification of novel variants in the LDLR gene in Russian patients with familial hypercholesterolemia using targeted sequencing","volume":"14","author":"Miroshnikova VV","year":"2021","unstructured":"Miroshnikova VV, Romanova OV, Ivanova ON, et al.. Identification of novel variants in the LDLR gene in Russian patients with familial hypercholesterolemia using targeted sequencing. Biomed Rep. 2021, 14:15. 10.3892\/br.2020.1391","journal-title":"Biomed Rep"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jlr.2021.100062","article-title":"Lipoprotein metabolism in familial hypercholesterolemia","volume":"62","author":"Chemello K","year":"2021","unstructured":"Chemello K, Garc\u00eda-Nafr\u00eda J, Gallo A, Mart\u00edn C, Lambert G, Blom D. Lipoprotein metabolism in familial hypercholesterolemia. J Lipid Res. 2021, 62:100062. 10.1016\/j.jlr.2021.100062","journal-title":"J Lipid Res"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3390\/jpm10020023","article-title":"A global review on the utility of genetic testing for familial hypercholesterolemia","volume":"10","author":"Hendricks-Sturrup RM","year":"2020","unstructured":"Hendricks-Sturrup RM, Clark-LoCascio J, Lu CY. A global review on the utility of genetic testing for familial hypercholesterolemia. J Pers Med. 2020, 10:10.3390\/jpm10020023","journal-title":"J Pers Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0092703","article-title":"Functional characterization of two low-density lipoprotein receptor gene mutations in two Chinese patients with familial hypercholesterolemia","volume":"9","author":"Wang H","year":"2014","unstructured":"Wang H, Xu S, Sun L, Pan X, Yang S, Wang L. Functional characterization of two low-density lipoprotein receptor gene mutations in two Chinese patients with familial hypercholesterolemia. PLoS One. 2014, 9:e92703. 10.1371\/journal.pone.0092703","journal-title":"PLoS One"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1194\/jlr.M200470-JLR200","article-title":"Identification and characterization of LDL receptor gene mutations in hyperlipidemic Chinese","volume":"44","author":"Chang JH","year":"2003","unstructured":"Chang JH, Pan JP, Tai DY, et al.. Identification and characterization of LDL receptor gene mutations in hyperlipidemic Chinese. J Lipid Res. 2003, 44:1850-8. 10.1194\/jlr.M200470-JLR200","journal-title":"J Lipid Res"},{"key":"ref16","doi-asserted-by":"crossref","DOI":"10.1146\/annurev.ge.24.120190.001025","article-title":"The LDL receptor locus in familial hypercholesterolemia: mutation analysis of a membrane protein","volume":"24","author":"Hobbs HH","year":"1990","unstructured":"Hobbs HH, Russel DW, Brown MS, Goldstein JL. The LDL receptor locus in familial hypercholesterolemia: mutation analysis of a membrane protein. Ann Rev Genet. 1990, 24:133-10.","journal-title":"Ann Rev Genet"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehv157","article-title":"Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatment","volume":"36","author":"Wiegman A","year":"2015","unstructured":"Wiegman A, Gidding SS, Watts GF, et al.. Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatment. Eur Heart J. 2015, 36:2425-37. 10.1093\/eurheartj\/ehv157","journal-title":"Eur Heart J"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3390\/life13071542","article-title":"Novel LDLR variant in familial hypercholesterolemia: NGS-based identification, in silico characterization, and pharmacogenetic insights","volume":"13","author":"Athar M","year":"2023","unstructured":"Athar M, Toonsi M, Abduljaleel Z, Bouazzaoui A, Bogari NM, Dannoun A, Al-Allaf FA. Novel LDLR variant in familial hypercholesterolemia: NGS-based identification, in silico characterization, and pharmacogenetic insights. Life (Basel). 2023, 13:10.3390\/life13071542","journal-title":"Life (Basel)"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2018.09.039","article-title":"Detecting familial hypercholesterolemia earlier in life by actively searching for affected children: the DECOPIN project","volume":"278","author":"Ibarretxe D","year":"2018","unstructured":"Ibarretxe D, Rodr\u00edguez-Borjabad C, Feliu A, Bilbao J\u00c1, Masana L, Plana N. Detecting familial hypercholesterolemia earlier in life by actively searching for affected children: the DECOPIN project. Atherosclerosis. 2018, 278:210-6. 10.1016\/j.atherosclerosis.2018.09.039","journal-title":"Atherosclerosis"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehz455","article-title":"2019 ESC\/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk","volume":"41","author":"Mach F","year":"2020","unstructured":"Mach F, Baigent C, Catapano AL, et al.. 2019 ESC\/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur Heart J. 2020, 41:111-88. 10.1093\/eurheartj\/ehz455","journal-title":"Eur Heart J"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.116.024541","article-title":"Predicting cardiovascular events in familial hypercholesterolemia: the SAFEHEART registry (Spanish Familial Hypercholesterolemia Cohort Study)","volume":"135","author":"P\u00e9rez de Isla L","year":"2017","unstructured":"P\u00e9rez de Isla L, Alonso R, Mata N, et al.. Predicting cardiovascular events in familial hypercholesterolemia: the SAFEHEART registry (Spanish Familial Hypercholesterolemia Cohort Study). Circulation. 2017, 135:2133-44. 10.1161\/CIRCULATIONAHA.116.024541","journal-title":"Circulation"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/334156-importance-of-genotype-phenotype-correlation-in-the-population-screening-of-familial-hypercholesterolemia","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T02:04:14Z","timestamp":1739930654000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/334156-importance-of-genotype-phenotype-correlation-in-the-population-screening-of-familial-hypercholesterolemia"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,18]]},"references-count":21,"URL":"https:\/\/doi.org\/10.7759\/cureus.79252","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2,18]]}}}